{{Rsnum
|rsid=2657888
|Gene=RBMS2
|Chromosome=12
|position=56544599
|Orientation=plus
|GMAF=0.3788
|Gene_s=RBMS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 38.1 | 48.7 | 13.3
| HCB | 51.1 | 40.9 | 8.0
| JPT | 44.2 | 48.7 | 7.1
| YRI | 17.8 | 50.0 | 32.2
| ASW | 24.1 | 37.0 | 38.9
| CHB | 51.1 | 40.9 | 8.0
| CHD | 58.7 | 33.0 | 8.3
| GIH | 16.8 | 57.4 | 25.7
| LWK | 12.7 | 52.7 | 34.5
| MEX | 62.1 | 27.6 | 10.3
| MKK | 12.9 | 43.9 | 43.2
| TSI | 49.0 | 44.1 | 6.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22479202
|Trait=None
|Title=Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.
|RiskAllele=T
|Pval=0.000008
|OR=0.0190
|ORtxt=None
|OA=1
}}

{{PMID|17362836}} Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}